Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 5851-5900 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT07103096
Infiltration in Rheumatology With 3D Virtual Reality Headset Pilot Study for the Evaluation of Satisfaction (ICARE)
N/A
Recruiting
30 participants
Started: May 28, 2025 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT07124546
Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers
NA
Recruiting
60 participants
Started: May 28, 2025 · Completed: May 30, 2027
1 condition
1 sponsor
1 location
NCT07121660
Post-operative Changes Study
N/A
Recruiting
17 participants
Started: May 28, 2025 · Completed: May 31, 2027
2 conditions
3 sponsors
1 location
NCT07009405
Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
NA
Recruiting
10 participants
Started: May 28, 2025 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06884592
Determination of the Frequency and Predictors of Difficult Intubation in Septoplasty Operations
N/A
Recruiting
300 participants
Started: May 28, 2025 · Completed: May 30, 2026
5 conditions
1 sponsor
1 location
NCT06782373
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
PHASE2
Recruiting
78 participants
Started: May 28, 2025 · Completed: Aug 31, 2027
2 conditions
2 sponsors
40 locations
NCT06931405
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
PHASE2
Recruiting
105 participants
Started: May 28, 2025 · Completed: Dec 31, 2026
2 conditions
1 sponsor
32 locations
NCT06942936
A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants
PHASE1
Recruiting
50 participants
Started: May 28, 2025 · Completed: Feb 6, 2026
1 condition
2 sponsors
2 locations
NCT06160284
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
PHASE1
Recruiting
12 participants
Started: May 28, 2025 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
PHASE3
Recruiting
830 participants
Started: May 28, 2025 · Completed: Apr 15, 2031
1 condition
5 sponsors
1 location
NCT06603363
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
NA
Recruiting
140 participants
Started: May 28, 2025 · Completed: Dec 15, 2028
10 conditions
3 sponsors
1 location
NCT06785064
Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance
NA
Recruiting
544 participants
Started: May 28, 2025 · Completed: Feb 28, 2029
4 conditions
2 sponsors
1 location
NCT06912984
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
NA
Recruiting
242 participants
Started: May 28, 2025 · Completed: Jul 31, 2029
3 conditions
2 sponsors
1 location
NCT06357299
Assessing Better Bottles for Babies
NA
Recruiting
76 participants
Started: May 28, 2025 · Completed: May 1, 2026
3 conditions
2 sponsors
1 location
NCT06995144
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
PHASE4
Recruiting
20 participants
Started: May 28, 2025 · Completed: Mar 15, 2026
4 conditions
1 sponsor
1 location
NCT06971640
Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition
N/A
Recruiting
250 participants
Started: May 28, 2025 · Completed: Nov 30, 2029
2 conditions
2 sponsors
1 location
NCT06976268
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
PHASE2/PHASE3
Recruiting
550 participants
Started: May 28, 2025 · Completed: Sep 30, 2027
1 condition
1 sponsor
65 locations
NCT06682988
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
PHASE2
Recruiting
110 participants
Started: May 28, 2025 · Completed: Mar 31, 2028
5 conditions
1 sponsor
15 locations
NCT06666322
Platform Trial For Cryptococcal Meningitis
PHASE2/PHASE3
Recruiting
2,000 participants
Started: May 28, 2025 · Completed: Apr 21, 2032
2 conditions
1 sponsor
2 locations
NCT06564623
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
PHASE1
Recruiting
25 participants
Started: May 27, 2025 · Completed: May 31, 2029
1 condition
3 sponsors
1 location
NCT06937307
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
PHASE2
Recruiting
75 participants
Started: May 27, 2025 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT06420375
Treatment of UC With Novel Therapeutics
PHASE2
Recruiting
20 participants
Started: May 27, 2025 · Completed: Jul 31, 2027
2 conditions
1 sponsor
1 location
NCT06757647
Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PHASE2
Recruiting
61 participants
Started: May 27, 2025 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
NCT06945107
A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy
PHASE3
Recruiting
310 participants
Started: May 27, 2025 · Completed: Jan 19, 2027
1 condition
1 sponsor
1 location
NCT06932757
Adjuvant Quisinostat in High-Risk Uveal Melanoma
PHASE2
Recruiting
63 participants
Started: May 27, 2025 · Completed: May 27, 2030
1 condition
3 sponsors
1 location
NCT06088953
EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER
NA
Recruiting
200 participants
Started: May 27, 2025 · Completed: Aug 27, 2027
2 conditions
1 sponsor
1 location
NCT07062770
Assessment of Circuit Rebreathing During CPAP Therapy
NA
Recruiting
13 participants
Started: May 27, 2025 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT06870812
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
NA
Recruiting
600 participants
Started: May 27, 2025 · Completed: Mar 31, 2030
1 condition
2 sponsors
3 locations
NCT07062744
The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock
NA
Recruiting
108 participants
Started: May 27, 2025 · Completed: Dec 30, 2027
9 conditions
2 sponsors
1 location
NCT06782932
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
PHASE1/PHASE2
Recruiting
38 participants
Started: May 27, 2025 · Completed: Dec 31, 2028
1 condition
4 sponsors
1 location
NCT07059572
Comparative Evaluation of Guava Leaf Extract and Chlorhexidine Mouthwash in Patients With Chronic Gingivitis
NA
Recruiting
160 participants
Started: May 27, 2025 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT06954584
Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer
PHASE3
Recruiting
424 participants
Started: May 27, 2025 · Completed: Mar 1, 2032
1 condition
1 sponsor
2 locations
NCT07021560
Wearability of and Myopia Progression With ZEISS MyoCare Spectacle Lenses
NA
Recruiting
90 participants
Started: May 27, 2025 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT06873334
Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease
PHASE2/PHASE3
Recruiting
120 participants
Started: May 27, 2025 · Completed: Dec 31, 2027
2 conditions
1 sponsor
10 locations
NCT06536166
Ruxolitinib Treatment in Inclusion Body Myositis
PHASE2
Recruiting
80 participants
Started: May 27, 2025 · Completed: Sep 10, 2028
1 condition
1 sponsor
16 locations
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
PHASE2
Recruiting
645 participants
Started: May 27, 2025 · Completed: Mar 31, 2028
4 conditions
1 sponsor
49 locations
NCT06980428
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels
PHASE1
Recruiting
120 participants
Started: May 27, 2025 · Completed: Dec 4, 2026
1 condition
1 sponsor
5 locations
NCT06810713
Evaluation of a Training for Healthcare Providers in Supporting Men Experiencing Suicidal Ideation
NA
Recruiting
120 participants
Started: May 27, 2025 · Completed: Dec 15, 2025
2 conditions
1 sponsor
1 location
NCT06130826
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
PHASE1
Recruiting
24 participants
Started: May 27, 2025 · Completed: Sep 5, 2026
2 conditions
2 sponsors
1 location
NCT06615908
Treatment of Persistent Post-concussive Symptoms With Psilocybin Assisted Therapy
PHASE1
Recruiting
40 participants
Started: May 27, 2025 · Completed: Mar 30, 2027
1 condition
2 sponsors
1 location
NCT06323954
tVNS During Motor Training in Older Adults
NA
Recruiting
32 participants
Started: May 27, 2025 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT06908460
Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease
N/A
Recruiting
90 participants
Started: May 27, 2025 · Completed: Aug 26, 2027
1 condition
2 sponsors
1 location
NCT06395285
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
PHASE1
Recruiting
12 participants
Started: May 27, 2025 · Completed: May 31, 2026
1 condition
1 sponsor
4 locations
NCT06992778
Effectiveness and Acceptability of Remote Fine-Tuning of Hearing Aids in Danish Adults
NA
Recruiting
120 participants
Started: May 27, 2025 · Completed: Mar 30, 2026
4 conditions
2 sponsors
1 location
NCT07009288
A Study of Time-Restricted Eating in Childhood Cancer Survivors
NA
Recruiting
300 participants
Started: May 27, 2025 · Completed: May 1, 2031
1 condition
1 sponsor
4 locations
NCT07032584
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
NA
Recruiting
74 participants
Started: May 27, 2025 · Completed: Dec 31, 2029
3 conditions
3 sponsors
1 location
NCT07047209
Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)
PHASE2
Recruiting
40 participants
Started: May 27, 2025 · Completed: Apr 30, 2026
1 condition
1 sponsor
3 locations
NCT06978660
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
N/A
Recruiting
500 participants
Started: May 27, 2025 · Completed: Oct 31, 2025
1 condition
2 sponsors
6 locations
NCT06981195
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
PHASE2
Recruiting
100 participants
Started: May 27, 2025 · Completed: Jul 30, 2029
4 conditions
2 sponsors
1 location
NCT06410131
Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16
PHASE1
Recruiting
68 participants
Started: May 27, 2025 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
Previous
1
More pages
115
116
117
118
119
120
121
More pages
1333
Next